USANA HEALTH SCIENCES, INC. Payments to Acquire Held-to-maturity Securities
USANA HEALTH SCIENCES, INC. (USNA) reported Payments to Acquire Held-to-maturity Securities of $0 for the 12-month period ending 2021-01-02, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2021-03-02
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2018-12-29 was $4.72M.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2018-09-29 was $39.24M.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2015-01-03 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for the quarter ending 2014-09-27 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2021 was $0.00.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2018 was $86.40M.
- USANA HEALTH SCIENCES, INC. payments to acquire held-to-maturity securities for fiscal 2015 was $3.87M, a 55.21% decline from fiscal 2013.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2021-01-02 | $0.00 10-K · filed 2021-03-02 | |||
| 2019-12-28 | $0.00 10-K · filed 2021-03-02 | |||
| 2018-12-29 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $43.96M derived: sum of 2 quarters · filed 2021-03-02 | $86.40M 10-K · filed 2021-03-02 | |
| 2018-09-29 | $39.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $81.67M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $42.43M 10-Q · filed 2019-08-06 | |||
| 2015-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $2.38M derived: sum of 3 quarters · filed 2017-03-01 | $3.87M 10-K · filed 2017-03-01 |
| 2014-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.38M derived: sum of 2 quarters · filed 2015-11-12 | $3.87M 10-Q · filed 2015-11-12 | |
| 2014-06-28 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $3.87M 10-Q · filed 2015-08-12 | ||
| 2014-03-29 | $1.49M 10-Q · filed 2015-05-13 | |||
| 2013-12-28 | $8.64M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |